ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
22 hedge funds and large institutions have $123M invested in Elevation Oncology in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less capital invested
Capital invested by funds: $217M → $123M (-$94M)
70% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 20
Holders
22
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.64M | |
| 2 | +$1.45M | |
| 3 | +$186K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$144K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$94K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$1.7M | |
| 3 | -$1.7M | |
| 4 |
Millennium Management
New York
|
-$1.67M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.36M |